Overview

Efficacy/ Safety of DNN.22.17.036 in Male Patients With Pattern Hair Loss

Status:
NOT_YET_RECRUITING
Trial end date:
2025-05-01
Target enrollment:
Participant gender:
Summary
Evaluation of the efficacy and safety of DNN.22.17.036 versus 10573048700 in the treatment of male pattern hair loss.
Phase:
PHASE4
Details
Lead Sponsor:
Ache Laboratorios Farmaceuticos S.A.